Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05747716
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-28
First Post:
2023-02-18
Brief Title:
SBRT Combined With Fruquintinib Plus PD-1CTLA-4 Antibody for Third-line Treatment in mCRC
Sponsor:
Wuhan Union Hospital China
Organization:
Wuhan Union Hospital China
Organization Data
Organization:
Wuhan Union Hospital China
Class:
OTHER
Study ID:
MCRC-3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wuhan Union Hospital China
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None